ERBB2 and breast cancer: Significant differences in the TM were found between subtypes of BC, including Human epidermal growth factor 2 (HER2)- vs. HER2+, estrogen receptor (ER)- vs. ER+, and triple negative (TNG) vs. not-TNG (16).